In addition, a pan-cancer analysis of NUMB exon 9 inclusion utilizing TCGA RNA-sequencing data confirmed these prior studies and also reported upregulation of NUMB exon 9 across breast cancer subtypes as well as in ovarian, prostate, and testicular cancer (Table 4) (Zhang, 2022 #1146). This evidence concerns the gene NUMB and cancer.